Schedule 13D ownership disclosure
Oncobiologics, Inc.
Security class unavailable · CUSIP: 68235M105
Event date: 2018-05-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 77.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-18-000523
- Form type
- SC 13D
- Filer
- BioLexis Pte Ltd.
- CIK
- CIK 1716335
- Filed
- Jun 25, 2018
- Reporting period
- May 14, 2018
- Description
- Schedule 13D beneficial ownership